ClinicalTrials.Veeva

Menu

Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity

Procter & Gamble (P&G) logo

Procter & Gamble (P&G)

Status

Completed

Conditions

Dentine Hypersensitivity

Treatments

Drug: Negative control dentifrice
Drug: Positive control dentifrice
Drug: Stannous fluoride dentifrice

Study type

Observational

Funder types

Industry

Identifiers

NCT04005417
2019SnF2SensitivityAnalysis

Details and patient eligibility

About

The aim of this 11 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) on dentine hypersensitivity versus a positive or negative control dentifrice.

Enrollment

1,036 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Subjects were excluded from this study for the following reasons;

  • severe periodontitis
  • at discretionary of the Principal Investigator

Trial design

1,036 participants in 3 patient groups

Stannous fluoride dentifrice
Description:
Twice daily brushing
Treatment:
Drug: Stannous fluoride dentifrice
Positive control dentifrice
Description:
Twice daily brushing
Treatment:
Drug: Positive control dentifrice
Negative control dentifrice
Description:
Twice daily brushing
Treatment:
Drug: Negative control dentifrice

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems